miRagen Therapeutics, Inc.
6 clinical trials · Sponsor
◉ Watch miRagen Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study (NCT03837457) | miRagen Therapeutics, Inc. | 2019-10-01 |
| SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides (NCT03713320) | miRagen Therapeutics, Inc. | 2019-04-02 |
| Efficacy, Safety, and Tolerability of Remlarsen (MRG-201) Following Intradermal Injection in Subjects With a History of Keloids (NCT03601052) | miRagen Therapeutics, Inc. | 2018-06-11 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MRG-110 Following Intradermal Injection in Healthy Volunteers (NCT03603431) | miRagen Therapeutics, Inc. | 2018-04-09 |
Track miRagen Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.